Biotage AB (Biotage AB) 3-Year Book Growth Rate : 44.40% (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Biotage AB 3-Year Book Growth Rate?

Biotage AB's Book Value per Share for the quarter that ended in Mar. 2024 was $4.67.

During the past 12 months, Biotage AB's average Book Value per Share Growth Rate was 90.00% per year. During the past 3 years, the average Book Value per Share Growth Rate was 44.40% per year. During the past 5 years, the average Book Value per Share Growth Rate was 30.80% per year. During the past 10 years, the average Book Value per Share Growth Rate was 18.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Biotage AB was 44.40% per year. The lowest was -17.70% per year. And the median was 5.60% per year.

Competitive Comparison of Biotage AB's 3-Year Book Growth Rate

For the Medical Instruments & Supplies subindustry, Biotage AB's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biotage AB's 3-Year Book Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biotage AB's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Biotage AB's 3-Year Book Growth Rate falls into.

Biotage AB 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Biotage AB (OTCPK:BITGF) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Biotage AB 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Biotage AB's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotage AB (Biotage AB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotage AB (OTCPK:BITGF) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

BIOT:Sweden 0GRP:UK PQX1:Germany

Address

Vimpelgatan 5, Box 8, Uppsala, SWE, 751 03

Website

https://www.biotage.com

Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.